Healthcare -
Biotechnology - NASDAQ - US
$ 3.5
-0.293 %
$ 670 M
Market Cap
-8.29
P/E
ABUS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ABUS - Arbutus Biopharma Corporation
52 M
LAST VALUE
27.84%
2 YEAR CAGR
6.78%
5 YEAR CAGR
-1.53%
10 YEAR CAGR